Opko Health (OPK) Stock: Buy, Sell, or Hold?
OPK - Opko Health Inc.
$1.63
0.00 (0.00%)
â˛
5d:
+6.54%
30d:
-0.61%
90d:
+31.45%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 04, 2026
10d
Get Alerted When OPK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OPK is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OPK is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: OPK is currently trading at $1.63, which is considered slightly high relative to its 30-day fair value range of $1.45 to $1.68.
Technical Outlook: Technically, OPK is in a uptrend. Immediate support is located at $1.30, while resistance sits at $1.77.
Market Sentiment: OPK scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.15 (+154.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OPK is in a uptrend. Immediate support is located at $1.30, while resistance sits at $1.77.
Market Sentiment: OPK scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.15 (+154.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.45 -
$1.68
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 154.6% below Wall St target ($4.15)
- WARNING: Composite score 37/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.45 -
$1.68
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.30
Resistance Level
$1.77
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.75
Wall Street Target
$4.15
(+154.6%)
Revenue Growth (YoY)
4.3%
Earnings Growth (YoY)
-12.6%
Profit Margin
-12.4%
Share & Embed Analysis
Last updated: October 24, 2026 12:18 AM ET
Data refreshes hourly during market hours. Next update: 1:18 AM
Data refreshes hourly during market hours. Next update: 1:18 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 67 BUY |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
28 analysts |
$691 | 48 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 45 HOLD |
